BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11332426)

  • 1. Prostate cancer screening.
    Stattin P; Stenman UH; Riboli E; Hallmans G; Kaaks R
    Lancet; 2001 Apr; 357(9263):1202-3. PubMed ID: 11332426
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer screening.
    Finne P; Auvinen A; Stenman UH
    Lancet; 2001 Apr; 357(9263):1201; author reply 1201-2. PubMed ID: 11330269
    [No Abstract]   [Full Text] [Related]  

  • 3. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening?
    Wolk A; Andersson SO; Mantzoros CS; Trichopoulos D; Adami HO
    Lancet; 2000 Dec; 356(9245):1902-3. PubMed ID: 11130391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening.
    Ablin AJ
    Lancet; 2001 Apr; 357(9263):1201-2; author reply 1201-2. PubMed ID: 11332425
    [No Abstract]   [Full Text] [Related]  

  • 5. Making sense of PSA.
    Thompson IM
    Health News; 2001 Apr; 7(4):3. PubMed ID: 11303477
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
    Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer screening.
    Mannello F; Gazzanelli G
    Lancet; 2001 Apr; 357(9263):1202. PubMed ID: 11379564
    [No Abstract]   [Full Text] [Related]  

  • 8. A more accurate prostate test?
    Health News; 2001 Jan; 7(1):6. PubMed ID: 11198413
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulatory mechanisms in prostate cancer.
    Jefferson K; Dwivedi A; Persad R; Holly J
    Lancet; 2000 Mar; 355(9209):1100-1. PubMed ID: 10744117
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 12. Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer.
    Smith GL; Doherty AP; Mitchell H; Hanham IW; Christmas TJ; Epstein RJ
    Lancet; 1999 Dec; 354(9195):2053-4. PubMed ID: 10636379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
    Nam RK; Trachtenberg J; Jewett MA; Toi A; Evans A; Emami M; Narod SA; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1270-3. PubMed ID: 15894684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 15. PSA screening.
    Cohen S; Schiff S; Kelty P
    Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) as serum markers of prostate cancer].
    Matsubara A; Nakamoto T; Usui T
    Nihon Rinsho; 2000 Jul; 58 Suppl():157-62. PubMed ID: 11022706
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum insulin-like growth factor I/free prostate specific antigen (IGF-I/fPSA) ratio enhances prostate cancer detection in men with total PSA 4.0-10.0 ng/ml.
    Zhigang Z; Jieming L; Su L; Wenlu S
    J Surg Oncol; 2007 Jul; 96(1):54-61. PubMed ID: 17345593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening.
    Catalona WJ
    BJU Int; 2004 Nov; 94(7):964-6. PubMed ID: 15541107
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for prostate cancer: the role of prostate-specific antigen.
    Ferrer RL
    Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.